A detailed history of Murphy Pohlad Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Murphy Pohlad Asset Management LLC holds 1,581 shares of ABBV stock, worth $260,849. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,581
Previous 1,775 10.93%
Holding current value
$260,849
Previous $304,000 2.63%
% of portfolio
0.13%
Previous 0.13%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$163.84 - $199.33 $31,784 - $38,670
-194 Reduced 10.93%
1,581 $312,000
Q2 2024

Jul 17, 2024

SELL
$154.79 - $180.76 $1,547 - $1,807
-10 Reduced 0.56%
1,775 $304,000
Q1 2024

Apr 12, 2024

SELL
$159.82 - $182.1 $7,991 - $9,105
-50 Reduced 2.72%
1,785 $325,000
Q4 2023

Jan 19, 2024

BUY
$137.6 - $154.97 $6,880 - $7,748
50 Added 2.8%
1,835 $284,000
Q2 2023

Jul 20, 2023

SELL
$132.51 - $164.9 $9,938 - $12,367
-75 Reduced 4.03%
1,785 $240,000
Q1 2023

Apr 17, 2023

SELL
$144.61 - $166.54 $25,306 - $29,144
-175 Reduced 8.6%
1,860 $296,000
Q4 2022

Feb 06, 2023

SELL
$138.31 - $165.87 $14,937 - $17,913
-108 Reduced 5.04%
2,035 $329,000
Q3 2022

Oct 24, 2022

BUY
$134.21 - $153.93 $2,549 - $2,924
19 Added 0.89%
2,143 $287,000
Q1 2021

Apr 20, 2021

BUY
$102.3 - $112.62 $5,115 - $5,631
50 Added 2.41%
2,124 $229,000
Q4 2020

Feb 05, 2021

BUY
$80.49 - $108.67 $166,936 - $225,381
2,074 New
2,074 $222,000
Q3 2020

Nov 09, 2020

SELL
$85.91 - $100.83 $178,177 - $209,121
-2,074 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$73.37 - $98.18 $152,169 - $203,625
2,074 New
2,074 $203,000
Q1 2019

May 07, 2019

SELL
$77.14 - $90.79 $184,133 - $216,715
-2,387 Closed
0 $0
Q3 2017

Oct 26, 2017

BUY
$69.85 - $89.22 $166,731 - $212,968
2,387
2,387 $212,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Murphy Pohlad Asset Management LLC Portfolio

Follow Murphy Pohlad Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Murphy Pohlad Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Murphy Pohlad Asset Management LLC with notifications on news.